Franz Gabor
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 20
-
- Hearing, Cochlea, Tinnitus, Genetics 12
- Co-authors
- Michael WirthLukas NeutschEva UntersmayrErika Jensen‐JarolimFritz PittnerChristoph ArnoldnerOtto ScheinerClemens Honeder
- Journals
- Journal of Controlled Release (10 papers)International Journal of Pharmaceutics (10 papers)European Journal of Pharmaceutics and Biopharmaceutics (9 papers)Pharmaceutical Research (5 papers)Acta Biomaterialia (4 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Franz Gabor
115 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 126
- Pharmaceutical Science 746
- Biomaterials 587
- Sensory Systems 157
- Neurology 215
- Immunology and Allergy 146
Countries citing papers authored by Franz Gabor
This map shows the geographic impact of Franz Gabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Gabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Gabor more than expected).
Fields of papers citing papers by Franz Gabor
This network shows the impact of papers produced by Franz Gabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Gabor. The network helps show where Franz Gabor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Franz Gabor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2021 | 1 | |
| 6 | 2018 | 12 | |
| 7 | 2016 | 32 | |
| 8 | 2015 | 4 | |
| 9 | 2014 | 37 | |
| 10 | 2014 | 6 | |
| 11 | 2012 | 3 | |
| 12 | 2011 | 48 | |
| 13 | Quantification of biodegradable PLGA nanoparticles for drug targeting | 2010 | 2 |
| 14 | 2010 | 74 | |
| 15 | 2008 | 2 | |
| 16 | 2001 | 42 | |
| 17 | 1998 | 72 | |
| 18 | 1995 | 2 | |
| 19 | 1995 | 4 | |
| 20 | 1993 | 35 |
About Franz Gabor
Franz Gabor is a scholar working on Pharmaceutical Science, Sensory Systems, Neurology, Otorhinolaryngology and Endocrinology, having authored 116 papers that have together received 3.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (20 papers), Glycosylation and Glycoproteins Research (15 papers), Hearing, Cochlea, Tinnitus, Genetics (12 papers), Nanoparticle-Based Drug Delivery (11 papers), Bladder and Urothelial Cancer Treatments (11 papers), Vestibular and auditory disorders (10 papers), Microfluidic and Bio-sensing Technologies (9 papers) and Transgenic Plants and Applications (8 papers). The work is most often cited by research in Pharmaceutical Science (746 citations), Biomaterials (587 citations), Sensory Systems (157 citations), Neurology (215 citations) and Immunology and Allergy (146 citations). Franz Gabor has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Michael Wirth, Lukas Neutsch, Eva Untersmayr, Erika Jensen‐Jarolim, Fritz Pittner, Christoph Arnoldner, Otto Scheiner, Clemens Honeder, Juan M. Irache and Christian R. Noe. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.